Milestone Scientific appoints Dr. Didier Demesmin as independent director

MILESTONE SCIENTIFIC INC.

Appointed September 6, 2023 as independent director by unanimous board vote.
Dr. Demesmin is CEO/Medical Director of University Pain Medicine Center since 2007.
Director of Pain Management at St. Peter's University Hospital since 2006.
Holds clinical faculty positions at Rutgers RWJ Medical School and several hospital pain medicine departments.
Earned MD from UMDNJ and MBA from Northwestern Kellogg in 2018.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Didier Demesmin

independent director

MLSS · MILESTONE SCIENTIFIC INC.

Effective: 2023-09-06
Filed: September 12, 2023, 7:59 PM ET

On September 6, 2023, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Dr. Didier Demesmin as an independent director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Didier Demesmin was appointed as independent director at MILESTONE SCIENTIFIC INC..

Action: appointed
Role: independent director

Exact text from the filing

On September 6, 2023, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Dr. Didier Demesmin as an independent director of the Company.

View on SEC.gov

MILESTONE SCIENTIFIC INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-025653

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.